Central Monitoring – Central Monitoring Summit

Successfully introducing new drugs and therapies in a quicker and more cost-effective manner starts in the most complex phase on of drug development; the clinical phase. The implementation of risk-based monitoring increases the overall quality of data while providing better oversight of patient safety. With the introduction of centralized monitoring in a risk-based monitoring approach, pharmaceutical companies are able to embrace a real-time overview of data and risk detection.

The Central Monitoring Summit will arm delegates with the tools they need to optimize existing clinical operation platforms and build quality into the design for a sound central monitoring foundation. Join your colleagues and our expert speaking staff as they provide in-depth insights into shifting your monitoring processes from an excessive concentration of data to risk-driven monitoring that uses central monitoring and technology enablement.

Featured Speakers

Special Focus

Discuss Case Studies and Practical Solutions Across Pharma on the Successful Implementation of Centralized Monitoring
Adopt Change Management and Infrastructure Changes Needed in Adoption of Central and Remote Monitoring Practices
Fine-Tune Responsibilities or Job Description of the Central Monitor
Use Predictive Analysis for a Central CRA or Study Manager to Understand the Trends in Clinical Data and to See Critical Development Earlier

Who Should Attend

This conference is designed for Life Sciences representatives with responsibilities in:

  • Monitoring
  • Medical Review
  • Clinical Data/Trial Management
  • Trial Innovation/Design
  • Biostatistics
  • Quality Management
  • Clinical Research Associates (CRAs)
  • Drug Safety


The conference will benefit monitoring supplier groups, including:

  • CROs
  • Risk-Based Monitoring Vendors
  • Electronic Data Capture (EDC)
  • Clinical Analytics
End Date

Address : Central Monitoring Summit